Medicine

On social media and blogs, it’s sometimes claimed that levothyroxine can be used for weight loss. For people living with overweight or obesity, it can be confusing to know what’s actually true. This article explains the risks and what may be useful to know about levothyroxine and weight loss.

‍

Modern medical treatment for overweight and obesity helps many people lose weight, improve their health, and maintain a lower weight over time. However, some experience side effects such as nausea, heartburn, or constipation. For most people, these symptoms are most common at the beginning of treatment and during dose increases. The side effects are usually mild and can often be prevented.

‍

Metformin is one of the most widely used medical treatments for type 2 diabetes. At the same time, this medication often appears in discussions about weight and metabolism. But why is metformin talked about in connection with weight loss, how strong is the effect really, and what risks do patients need to be aware of?

In this article, various aspects of treating overweight and obesity with the medication Mysimba are discussed, and information is provided on how the risk of disease can be reduced through conscious choices regarding diet, physical activity, and medical treatment.

‍

According to the WHO, overweight and obesity affect nearly 60 per cent of the adult population in Europe, highlighting the need for integrated treatment strategies that combine medical therapy with lifestyle changes (1).

We are in a new era of obesity treatment. GLP-1-based medicines have transformed the landscape – but real success is achieved when medication becomes part of a comprehensive approach that supports the whole person.

Long-term health and weight loss require more than medicine alone. It is when medical treatment is combined with lifestyle change and continuous guidance that meaningful, lasting progress becomes possible (1–2).

Trulicity is a medicine that contains the active substance dulaglutide. It is approved for the treatment of adults with type 2 diabetes to improve glycaemic control as a complement to a healthy diet and physical activity (1). The treatment may also contribute to weight loss (2–4).

Saxenda is a medicine used as support in the treatment of overweight and obesity. It contains the active substance liraglutide, which influences appetite regulation and helps reduce energy intake. When combined with lifestyle changes such as a healthy diet and regular physical activity, the treatment can support clinically significant weight loss (1).

‍

Rybelsus is a medicine containing the active substance semaglutide. It is approved for the treatment of adults with type 2 diabetes to improve glycaemic control as a complement to a healthy diet and physical activity.

The treatment may also contribute to weight loss (1,2).

‍

Mounjaro is a medicine that can help people living with type 2 diabetes – as well as those with overweight or obesity – to regulate blood sugar, improve their health and achieve sustainable weight loss. To make an informed decision about treatment, it is important to understand how Mounjaro works, who it is suitable for, and how it can support long-term lifestyle change.

‍

Ozempic is a prescription medicine containing semaglutide as its active substance. This medicine was originally approved for the treatment of type 2 diabetes, but has since also been shown to contribute to clinically significant weight loss. Semaglutide has demonstrated significant improvements in body weight and metabolic markers in studies involving individuals with overweight or obesity. To make an informed decision about treatment, it is important that the person receives accurate information about how Ozempic works, who it is suitable for, and how it may affect long-term health (1,2).

‍

Wegovy is a prescription medicine that can help people living with overweight or obesity lose weight in an effective and safe way. It is important to understand how Wegovy works, who may benefit from the treatment, and how the medicine affects weight loss and health. To make an informed decision about treatment with Wegovy, it is essential to have access to accurate and sufficient information.

An increasing number of people today are living with overweight or obesity. Semaglutide has become one of the most effective medical treatments to help many people lose weight (1).

Semaglutide was originally developed as a treatment for type 2 diabetes, but clinical trials showed significant weight loss. The medication Wegovy (semaglutide 2.4 mg) is currently approved for weight management in adults with a BMI ≥ 30, or ≥ 27 with weight-related comorbidity (2).

Obesity is now one of the world’s greatest public health challenges. According to the WHO, more than 1 billion people worldwide have obesity, including over 650 million adults and 340 million children and adolescents. The prevalence has more than tripled since 1975 and continues to rise in almost every part of the world.

Having severe overweight or obesity is not only about body weight but about health. A high proportion of body fat increases the risk of many different diseases, such as type 2 diabetes, cardiovascular disease, osteoarthritis and certain types of cancer (1).

‍

‍

Obesity in men extends beyond physical health—it intertwines with psychological and societal pressures that shape behavior, self-image, and overall wellbeing.

Obesity significantly impacts men’s hormonal health — particularly testosterone — increasing risks of fatigue, weight gain, and chronic disease; understanding this connection is key to effective treatment and long-term wellbeing.

Excess weight affects men’s physical, hormonal, and mental health in complex ways—understanding these challenges is key to achieving sustainable weight loss and improved wellbeing.

Obesity in men is more than a weight issue — it’s a complex medical condition with far-reaching health risks. From heart disease and liver problems to hormonal and psychological effects, understanding these connections is key to effective prevention and management.

Many men think major weight loss is needed for real results, but even small reductions can greatly boost heart health, hormones, and overall wellbeing.

Discover how Yazen uses blood tests and health screenings to uncover hidden barriers to weight loss and create safe, personalised treatment plans.

At Yazen, we focus on helping women lose weight — a key factor in improving fertility and increasing the chances of pregnancy — through expert, personalised care.

Lipedema is a misunderstood and often misdiagnosed condition that causes painful fat accumulation — Yazen explains the symptoms, causes, and treatment options.

Menopause often brings unexpected weight gain, but with Yazen’s expert support, women can take control of their health and feel confident through every stage.

Polycystic ovary syndrome (PCOS) affects millions of women—and at Yazen, we help you manage symptoms, improve fertility, and take control of your weight and health.

Hypothyroidism is a common condition, especially among British women—and at Yazen, we’re here to help you understand and manage it with confidence.

At Yazen, we support women through the physical, emotional, and hormonal aspects of weight—offering tailored treatment and compassionate care.